Stocktwits on MSN
MRK, NEUP stocks drop as Merck scraps another Alzheimer’s drug trial under Neuphoria partnership
The trial tested whether adding MK-1167, a daily capsule, to standard Alzheimer’s medicines could improve memory and thinking. ・Merck ended the trial after an early planned review of the results ...
When most people think about Alzheimer's disease, memory loss is usually the first thing that comes to mind. Forgetting a loved one's name, missing appointments or repeatedly misplacing everyday items ...
Learn how to build a second brain using Claude and Obsidian to create a persistent, local AI memory that remembers your conversations and preferences, enhancing your chatbot experience. Follow a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results